| abstract |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to a combination and a pharmaceutical preparation used for treating inflammatory for treating inflammatory and obstructive respiratory diseases. Said combination and preparation involve R,R-glycopyrrolate or its prolonged release physiologically acceptable salt and beta-mimetic agent selected from formoterol or salmeterol or their physiologically acceptable salts. Daily doses of said active ingredients make formoterol 1-72 mcg, salmeterol 10-300 mcg and R,R-glycopyrrolate 5-500 mcg. ^ EFFECT: invention provides a superadditive bronchospasmolytic effect with simultaneous reduction of side effects, and also anti-inflammatory action. ^ 9 cl, 3 ex |